During the last decade, advances in sequencing technologies allowed production of a wealth of information on epigenetic modifications in T cells. Epigenome maps, in combination with mechanistic studies, have demonstrated that T cells undergo extensive epigenome remodeling in response to signals, which has a strong effect on phenotypic stability and function of lymphocytes. In this review we focus on DNA methylation, histone modifications, and chromatin structure as important epigenetic mechanisms involved in controlling T-cell responses. In particular, we discuss epigenetic processes in light of the development, activation, and differentiation of CD4 1 T helper (T H ), regulatory T, and CD8 1 T cells. As central aspects of the adaptive immune system, we review mechanisms that ensure molecular memory, stability, plasticity, and exhaustion of T cells. We further discuss the effect of the tissue environment on imprinting T-cell epigenomes with potential implications for immunotherapy. (J Allergy Clin Immunol 2018;142:728-43.) 
T cells are a subtype of white blood cells, which play a major role in the adaptive immune system. They can be classified according to their specific function: MHC class II-restricted CD4-expressing T cells (CD4) can differentiate into specific T H subtypes. In contrast to this, MHC class I-restricted CD8-expressing T cells (CD8) are classically known for their potential to destroy virus-infected or tumor cells, hence their denomination as cytotoxic T lymphocytes (CTLs). Following development in the thymus from early T-cell precursor cells over CD4 and CD8 double-negative (DN) and double-positive (DP) stages, T cells finally differentiate into CD4 and CD8 single-positive (SP) thymocytes. On recognizing MHC-peptide complexes through their T-cell receptor (TCR), naive CD4 1 or CD8 1 T cells can differentiate into specific effector populations, which is guided by integrating TCR activation with a variety of other signals provided by immune and nonimmune cells. Importantly, after the initial immune response, a persistent pool of memory T cells maintains the capability to respond rapidly to antigen re-encounter, providing long-lasting protection.
All these phenotypic changes in T cells are accompanied by distinct gene-expression programs that equip T cells with the molecules needed to develop and exert their function, and it is of utmost importance for the integrity of the immune system that T cells establish and maintain those states in a highly controlled manner. This is achieved by diverse noncoding gene-regulatory elements in the genome. Proximal and distal regulatory elements (promoters and enhancers, respectively) can be bound by transcription factors (TFs), which cooperate with other proteins, such as remodeling complexes and epigenetic modifiers, to establish and maintain transcription-permissive or transcriptionrestrictive chromatin environments in a progressive manner. Accompanied modifications of the DNA and chromatin proteins that contribute to maintaining the cell state without changes in the DNA sequence itself (so-called epigenetic modifications) have been described to play a major role in development, activation, and polarization of lymphocytes.
In this review we focus on DNA methylation, histone modifications, and chromatin structure and discuss the recent global epigenome studies on CD4
1 T H cells, regulatory T (Treg) cells, and CTLs with respect to their development and function under physiologic or pathologic conditions.
EPIGENETIC MECHANISMS AND GENE REGULATION DNA methylation
In mammals the base cytosine is commonly modified by methylation of its carbon at position 5, predominantly in the context of CpG dinucleotides (mCpG). 1 The methylation mark can be written by de novo DNA methyltransferase (DNMT) 3A and DNMT3B with the help of DNMT3L. 2, 3 Once established, methylation patterns can be stably transmitted over cell divisions through maintenance DNMT1, and this inheritability designates DNA methylation as a true epigenetic mark. 4, 5 Long considered extremely stable, recent discoveries regarding the ten-eleven translocation (TET) family of proteins established the concept of catalyzed active demethylation (Fig 1, A) . 6 The effects of DNA methylation on transcriptional activity are complex. At CpG islands (regions of high CpG density), especially if located at promoters, DNA methylation causes repression of transcription, and high methylation levels support processes such as Xchromosome inactivation and imprinting. 1 In contrast, gene bodies of highly expressed genes are heavily methylated, with a possible effect on splicing, whereas a low degree of methylation is found at active gene-regulatory elements that are bound by TFs. [7] [8] [9] Hence, using methods of genome-wide DNA-methylation profiling, such as whole-genome bisulfite sequencing (WGBS), has been proved very useful to delineate cell type-specific aspects of gene regulation, identify cis-acting TFs, and describe cellular ontologies.
DNA methylation can affect gene expression in direct and indirect ways (Fig 1, B) . For instance, DNA methylation actively blocks the binding of certain TFs, hence restricting regulatory elements from receiving positive transcription signals. 1 Furthermore, it has recently been demonstrated that some TFs can actively recognize methylated DNA, and on binding, such factors can recruit other TFs to remodel a repressed chromatin environment toward an active one. 10 As an indirect mechanism, methylated DNA can be recognized by proteins, including methyl-CpG domain-binding (MDBs) proteins, which are able to recruit other chromatin-modifying enzymes, such as histone deacetylases (HDACs), 11 driving a repressed chromatin environment. Conversely, CXXC-type zinc finger protein 1 recognizes CpG islands and recruits activating histone methyltransferases that create a permissive chromatin environment. 12 
GLOSSARY CHROMATIN IMMUNOPRECIPITATION (ChIP):
An assay used to investigate interaction between proteins and DNA in the cell by evaluating transcription regulation through histone modification or transcription factor-DNA-binding interactions.
DIFFERENTIALLY METHYLATED REGION (DMR):
Regions of the genome with different methylation states that are considered functional regions involved in gene transcriptional regulation. Identifying DMRs among different tissues provides a comprehensive view of epigenetic differences among tissues.
ENHANCER OF ZESTE 2 POLYCOMB REPRESSIVE COMPLEX (EZH2):
A histone-lysine N-methyltransferase enzyme involved in histone methylation and maintaining transcriptional repression over successive cell generations. Mutation or overexpression of EZH2 has been associated with a variety of cancers, and its inhibition has been shown to be responsible for suppressing tumor development. Thus blocking EZH2 activity might slow tumor growth.
PROGRAMMED CELL DEATH PROTEIN 1 (PD-1): A cell-surface molecule that, when expressed on T cells, pro-B cells, and myeloid-derived dendritic cells, leads to negative regulation of proliferation and activity. PD-1 and its ligand, programmed death-ligand 1 (PD-L1), play a major role in suppressing the immune system by sending an inhibitory signal to reduce T-cell activity.
SUPERENHANCER: A region of the mammalian genome comprising multiple enhancers in close genomic proximity to drive transcription of genes critical for cell-type specification and function.
TEN-ELEVEN TRANSLOCATION (TET):
Proteins involved in regulation of DNA methylation and transcription named for a common translocation between chromosomes 10 and 11, creating an MLL-TET1 fusion protein found in patients with several forms of cancer.
TOPOLOGICALLY ASSOCIATED DOMAIN (TAD):
Linear units of chromatin that fold as discrete 3-dimensional structures and tend to favor internal, rather than external, physical chromatin interactions. It has been shown that disruption of TADs leads to disease because of the transformation of 3-dimensional organization and thus disrupting gene regulation.
WHOLE-GENOME BISULFITE SEQUENCING (WGBS):
A type of nextgeneration sequencing technology that has enabled genome-wide analysis of 5-methylcytosine (5mC) nucleotides at single nucleotide resolution by treating DNA with sodium bisulfite before sequencing. Sodium bisulfite converts unmethylated cytosines into uracil, and unconverted cytosines are methylated. This allows for detection of unmethylated cytosines to be detected as thymines after sequencing. Methylation of DNA at cytosine nucleotides forms 5mC, which affects various cellular processes involving gene expression and chromatin remodeling.
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Histone modifications
DNA is wrapped around nucleosomes consisting of 8 histone proteins (2 copies of each histone: H2A, H2B, H3, and H4) to form the basic organizational structure of genetic information, the chromatin. Histone proteins have nonglobular N-terminal tails that can harbor manifold posttranslational modifications, such as methylation, acetylation, phosphorylation, or ubiquitinylation. 13 More than a dozen classes of histone modifications are known to date, and the corresponding enzymes that set, remove, and interpret the marks have been identified (ie, writers, erasers, and readers; Fig 1, C) . 5 Chromatin immunoprecipitation (ChIP), followed by sequencing, allows genome-wide profiling of histone modifications, even from low cell numbers, and contributed significantly to the understanding of distribution and functional correlations of histone posttranslational modifications in gene regulation. [14] [15] [16] [17] In general, histone acetylation is regarded as an activating histone modification: histone H3 lysine 27 acetylation (H3K27ac) was described to mark active promoters and enhancers and is therefore useful to identify cis-regulatory elements. 18 Histone methylation is another very well-studied modification that has different effects on transcription dependence on which histone-tail residue is modified. Histone H3 lysine 4 trimethylation (H3K4me3) marks transcription-permissive promoters and transcribed enhancers, whereas histone H3 lysine 4 monomethylation (H3K4me1) is associated with poised enhancers. 19 Mechanistically, as an example, H3K4me3 can be bound by chromodomain-containing proteins, such as chromatin remodelers and histone acetyltransferases, which drive a relaxed chromatin structure to enable transcription. Contrary to H3K4 methylation, trimethylation of H3K27 (written by enhancer of zeste 2 polycomb repressive complex 2 subunit [EZH2]) is enriched at facultative heterochromatin and marks polycombrepressed genes involved in development, whereas constitutive heterochromatin is marked by H3K9me3. 20 Interestingly, bivalency, the co-occurrence of active and repressive histone modifications, was described, providing an intermediate activity state that can be resolved during development into activity or inactivity of associated genes. 21 Well-established crosstalk between histone modifications and DNA methylation exists, which contributes to stable regulation of gene expression. 11, 12 Importantly, histone modifications are reversible, and in this regard the complex interplay of histone readers, writers, and erasers in conjunction with DNA methylation and TF binding have a major effect on establishing and maintaining transcription. 5 
Chromatin accessibility
Because nucleosomes interact strongly with DNA, they are repressors per se that need to be removed to allow access to regulatory DNA sequences. Hence gene-regulatory elements are deprived of nucleosomes, rendering the underlying DNA susceptible for nuclease digestion or transposition events. This is exploited by methods such as DNase sequencing and assay for transposase-accessible chromatin (ATAC) sequencing, which map accessible chromatin regions, including enhancers, promoters, and boundary elements, genome-wide and allow the inference of putative TF-binding events at high resolution. 22, 23 In combination with histone modification, cell type-specific open chromatin regions connect the information of TF binding and chromatin attributes at cis-regulatory elements. 19 Comprehensive studies argue for a mechanistic model in which pioneer TFs can bind to closed or repressed chromatin regions to prime cis-regulatory regions by recruiting proteins that remodel nucleosomes and deposit activating histone modifications. 19 Once primed, the now more activated regulatory elements subsequently allow binding of signal-dependent and cell type-specific TFs to promote respective transcriptional programs (Fig 1, D) . 24, 25 To maintain accessible chromatin regions over cell divisions, TFs can reside on condensed mitotic chromatin as a bookmark, adding to the potential mechanisms of how molecular memory of gene activity can be preserved. 26 
Long-range chromatin interactions
The interplay of cis-regulatory elements in orchestration of gene expression is not a linear but rather a highly complex process based on 3-dimensional physical interactions in the nucleus. In mammalian nuclei, within relatively stable megabase-sized topologically associated domains (TAD), cell type-specific enhancer-promoter interactions can occur over hundreds of kilobases of distance to establish gene-regulatory programs. 27 Currently, sequencing methods based on the chromatin conformation capture assay 28, 29 are used to link the manifold discovered enhancer regions to their target promoters, which will be crucial to understand the role of individual enhancers in gene regulation. Long-range interactions are established and maintained by boundary proteins, such as CCCTC-binding factor; cohesins; and TFs, such as the mediator complex. 27 Importantly, longrange chromatin interactions can be formed even before the related genes are expressed, allowing rapid transcription on activating signals. 30 Furthermore, shared enhancers between cell types were shown to interact in a cell type-specific manner with different sets of promoters, indicating that not only cell type-specific but also common enhancers contribute to cell type-specific gene-regulatory programs. 31 
EPIGENETICS OF CD4
1 AND CD8
LINEAGE CHOICE IN THE THYMUS

Both CD4
1 and CD8 1 T cells are generated in the thymus, where each developmental step is characterized by discrete surface protein and transcriptional programs. In addition, T-cell fate is locked into developing thymocytes by a defined epigenetic program, marking a first epigenetic fixation step. 32, 33 Maturing through the DN and DP stages to the CD4 or CD8 SP stage, precise control of CD4 expression in TCRab CD4
1 T cells, as well as CD8 expression in TCRab CD8
1 CTLs, is another durable epigenetic memory installed in developing thymocytes. In both cases epigenetic marks, including repressive histone modifications and DNA methylation, can silence regulatory elements in alternative cell fates, thereby manifesting lineage decision. 34 
Locking the T-cell epigenetic program in developing thymocytes
Two recent publications investigated the epigenetic events accompanying T-cell commitment. 32, 33 A first study investigated chromatin accessibility through DNase sequencing combined with other techniques in 8 T-cell developmental steps from hematopoietic stem cells through DN to DP thymocytes. Interestingly, they detected that major genome-wide chromatin accessibility changes occurred during transition from DN2 to DN3, which is closely linked to T-cell commitment and mediated by Bcl-2-like protein 11 (BCL211b). 32 In parallel, another study investigated chromatin accessibility of hematopoietic stem cells, DN thymocytes, and mature CD4 SP or CD8 SP cells through ATAC sequencing. Their data revealed that chromatin is opened in discrete waves and that the TF TCF1 is crucial to establish J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 3 the specific chromatin landscape of T cells during their development.
33
CD4 versus CD8 lineage choice in the thymus
During thymic development, DP thymocytes differentiate into either CD4SP or CD8SP thymocytes, another lineage decision accompanied by epigenetic changes in the genome. CD4 expression is controlled by 3 enhancer elements (distal enhancer E4D, proximal enhancer E4p, and thymocyte enhancer E4T), 1 silencer element (S4), and the CD4 promoter. These elements have independent but cooperative functions affecting CD4 expression during thymocyte development. 35, 36 The proximal enhancer (E4p) is essential to establish active CD4 expression in thymocytes on an epigenetic basis, and its loss causes unstable CD4 expression in mature CD4
1 T cells. 37 On the other hand, silencing of CD4 expression in CD8 1 T cells is mediated through epigenetic marks at the CD4 silencer element (S4). Mutation of functional sites or binding sites for epigenetic modifiers in this silencer element results in expression of CD4 in all peripheral T cells. [38] [39] [40] In addition to epigenetic control of the CD4 locus, CD8 is also controlled through multiple enhancer sites in an epigenetic fashion. Two enhancer sites, E8I-E8V and E8II-E8V, have been identified. The E8I-E8V element is required for CD8 expression in intraepithelial lymphocytes and dendritic cells, whereas E8II-E8V is important for CD8 expression in mature CD8
1 T cells. Epigenetic regulation of these elements occurs through repressive marks and DNA methylation that is often orchestrated by superior TFs and epigenetic regulators. 34 After antigen recognition by the TCR, activated CD4 1 T cells are guided by specific costimulatory signals and the cytokine milieu to proliferate and then differentiate into various T H cells with diverging functions. Once activated, T H cells retain molecular memory of their activation to allow rapid responses when reencountering an antigen, which spawned research on the epigenetic mechanisms in memory formation. In fact, the ability of memory T cells to have accelerated responses in comparison with naive T cells is a major factor in the protective ability of our immune system. The classical paradigm of T H polarization has been revised, with the notion that T H subsets are more heterogeneous and convertible than initially anticipated, which is especially evident in pathogenic situations. These observations fostered increased epigenetic research on development and maintenance of different T H subtypes.
Epigenetics of CD4
1 T H cell activation and memory formation TCR activation is a central event in shaping cellular processes in lymphocytes in the context of an immune response. By activating a complex signaling cascade, naive T cells undergo internal reorganization in which they transform from a quiescent state to actively proliferating T-cell blasts. In the absence of TCR signaling, the formally activated T cells no longer express the inducible molecules normally associated with fully activated T cells but can re-express them rapidly on rechallenge. Insights into how this memory effect can be generated came from a study that probed the chromatin accessibility landscape of naive and blast T cells. They demonstrated that activation-induced nuclear factor of activated T cells (NFAT) and activator protein 1 (AP-1) TFs enable, in cooperation with constitutively expressed Runtrelated transcription factor (RUNX) and ETS proto-oncogene (ETS) TFs, the creation of thousands of new accessible chromatin sites that were preserved during replication and maintained in memory cells, even after the activating signals ceased. 42 The primed accessible genomic regions were maintained in the vicinity of inducible genes and enhancers that regulate immune responses, hence likely contributing to immunologic memory. However, a different study observed only a small increase in novel H3K4me2 marked enhancers on TCR stimulation, concluding that the CD4 1 T-cell enhancer landscape is pre-established to a relatively large extent. 43 Interestingly, a quantitative increase of histone acetylation at AP-1 bound enhancers was observed that reflected the graded strength of TCR signaling. 43 Similarly, the quality of TCR signaling determined differential affinities of enhancers for other TFs, such as basic leucine zipper TF, ATF-like (BATF) and interferon regulatory factor 4 (IRF4), 44 indicating that the initial T-cell activation amplitude is directly correlated to the extent of enhancer activation and hence likely shapes all following/parallel signals to the T cells.
Several studies explored correlations of histone modifications to the activity of linked genes in different CD4
1 memory T-cell populations. 45, 46 Positive histone modifications, such as H3K4 methylation and H3K27ac at promoters and enhancer elements, mark key signature cytokine genes, such as IFNG, IL4, and IL17A, as well as other genes that are strongly upregulated during secondary immune responses. On differentiation of naive T cells into effector T cells after primary activation, these characteristic cytokine genes were expressed, and once expression ceased on transition of effector into memory T cells, their promoter and enhancer elements still remained positively marked, leaving the chromatin in a permissive state. 45 These observations again argue for an epigenetic memory of effector function to ensure a rapid reactivation of T cells on antigen re-encounter.
By using comprehensive multi-(epi)genomics analysis of CD4 1 effector and memory T-cell populations, a segmented proliferation-related loss of DNA methylation and gene-specific epigenetic changes that control the stage-specific expression of transcriptional regulators were observed. 46 Progressive epigenome changes during T H cell differentiation suggest a linear model of T H cell differentiation and memory formation, and integrative analysis identified memory-specific TFs under epigenetic control. The proliferation-associated loss on DNA methylation has important implications for interpretation of results when analyzing DNA methylation in patients with disease because researchers need to ask the question of whether differential methylation patterns are a real attribute of disease-specific T-cell states or merely a bystander effect of proliferation.
Interestingly, many promoter and enhancer regions of differentially expressed genes between memory T-cell subsets were unmethylated, even in naive CD4
1 T cells, suggesting the preexistence of an enhancer landscape that is awaiting activation for lineage polarization (Fig 2, A) . 47 
1 T H cell polarization
The static T H 1/2 paradigm, 48 in which naive CD4 1 T cells can stably differentiate into the 2 functionally distinct subsets with either IFN-g/TNF-producing T H 1 cells or IL-4/IL-5/IL-13-producing T H 2 cells, has given way to a very dynamic picture of T H cell development and plasticity. After initial activation, cytokines and other environmental signals induce specific TFs that mediate genome-wide chromatin changes in CD4
1 T H cells in the context of general/developmentally regulated TFs, [49] [50] [51] [52] [53] proving that the enhancer landscapes of T H 1-, T H 2-, and T H 17-polarized cells differ remarkably. The importance of distal gene-regulatory elements is shown by the enrichment of disease-associated single nucleotide polymorphisms from genome-wide association studies in enhancers of T H cell subsets that play a major role in pathophysiology of the respective diseases. 51, 53 Well-studied key drivers of lineage-specific active enhancers are lineage-specific TFs, as well as signal-dependent TFs, such as signal transducer and activator of transcription (STAT) proteins (T-box transcription factor 21 [T-bet] and STAT1 for T H 1 cells, GATA3 and STAT6 for T H 2 cells, and retinoic acidrelated orphan receptor (ROR)gt and STAT3 for T H 17 cells), although further important key TFs have been described for each subset (Fig 2, B) . 54 Interestingly, primed enhancers marked by H3K4me1 before T-cell activation were less dependent on the lineage-specific TFs T-bet, GATA3, and RORgt, suggesting again a partially primed chromatin landscape before lineage specification that is exploited by polarization signal-dependent TFs on their activation. 49 More T H cell subsets and corresponding key TFs have been described. For example, T H 9 cells require PU.1 for their development and are also dependent on TFs, such as IRF4, IRF8, BATF, and FOXO1. 55, 56 T H 22 cells are driven by the TF AHR. 57 Follicular helper T (T FH ) cells require B-cell lymphoma 6 (BCL6), as well as cofactors, such as achaete-scute complex homolog 2 (ASCL2), MAF bZIP transcription factor (MAF), and IRF4.
58
Even more subsets are emerging, although sometimes unequivocal lineage-specific TFs and cofactors are still lacking. 59 Importantly, in addition to their activating properties, lineagespecific TFs were shown to repress corresponding alternative lineage-specific programs through direct binding and accompanied epigenetic silencing of key gene loci, which is well documented for classical cytokine and TF loci of the major CD4
1 T H cell subsets. As an example, differentiation of T H 2 cells is driven by IL-4, which induces STAT6 phosphorylation and activation to enhance transcription of GATA3. In turn, this protein, through specific distal enhancers (locus control regions [LCRs]), controls the T H 2-specific expression of IL-4, IL-5, and IL-13, which is accompanied by opening of chromatin and deposition of activating histone modifications at corresponding enhancers and promoters. 60 At the same time, GATA3 and STAT6 target the IFNG promoter, which correlates with binding of PRC1 and the H3K27 methyltransferase EZH2 to the IFNG locus, leading to a repressed environment at this key T H 1 cytokine. The well-described T H 2 polarization is also an excellent example of how long-range chromatin interactions accompany lineage specification. The T H 2 LCR already showed spatial proximity to the cytokine gene promoters in naive CD4
1 T cells before activation, indicating an already primed chromatin conformation for rapid cytokine induction. 30 Early reports show the physical interaction of chromosome loci to control cytokine expression, even over different chromosomes, 61 where the T H 2 LCR is in contact with the IFNG promoter. Recent findings suggest that the same enhancers can change long-range chromatin interactions with target promoters in a cell type-specific fashion. 31 Such enhancer switches were observed comparing long-range chromatin interactions of naive CD4 1 T, Treg, and T H 17 cells, indicating that the mere discovery of a gene-regulatory element needs to be investigated in a spatiotemporal context to decrypt its function.
Epigenetic plasticity of CD4
1 T H cells
In addition to the increasing complexity of lineage specification, significant plasticity and blurred demarcation of T H cell subsets is an emerging topic. To provide only a few selected examples, a highly stable T-bet 1
GATA-3
1 T H 1/T H 2 hybrid cell population that produced both IFN-g and IL-4 was described. 62 Furthermore, T H 1 cytokine expression was observed in T H 17 cells, as well as in Treg cells, in human disease settings, 63, 64 and polarized T H 1/T H 17/Treg cells can be pushed toward a T H 2 phenotype during helminth infections. 65 In patients with autoimmune arthritis, conversion of forkhead box protein P3 (Foxp3)
1 T cells into pathogenic T H 17 cells was described. 66 Because of the important role of epigenetic mechanisms in Tcell responses, it is anticipated that histone modifications and DNA methylation safeguard polarized phenotypes by both sustaining the correct gene-regulatory program and at the same time repressing the one of alternative lineages. As examples, DNA methylation plays a major role in specialization of T H cell subtypes because loss of the de novo methyltransferase DNMT3A causes inappropriate expression of the T H 1 signature cytokine IFN-g in alternative CD4
1 T-cell subtypes. 67 Loss of EZH2 enhanced the flexibility in cytokine expression when polarization conditions were switched from T H 1 to T H 2 and vice versa.
68
EZH2 is also involved in maintenance of Treg cell identity during cellular activation. 69 HDAC1 and HDAC2 maintain integrity of the CD4 lineage by repressing a CD8 1 effector T cell-like program in CD4
1 T cells. 70 The histone methyltransferase SUV39H1 participates in T H 2 lineage stability by maintaining silencing of T H 1 loci by repressing chromatin modifications. 70 Several possibilities could contribute to the observed plasticity and hybrid subsets. First, chronic environmental signals can overcome epigenetic safeguards to lineage stability. As lineages, it was described that some key TFs showed a different picture. 74 Tbx21, the gene coding for the TF T-bet, showed only activating H3K4me3 at the promoter in T H 1-polarized cells but bivalent modifications (H3K4me3 and H3K27me3) in all other investigated subsets, and Gata3 showed only H3K4me3 in T H 2-polarized cells but bivalent modifications in the other subsets, suggesting that these TFs are not stably repressed but could potentially be activated in other lineages. This could significantly contribute to generation of the abovementioned T H 1/T H 2 hybrid cells on interferon signaling, which potentially creates a unique gene-regulatory landscape by inducing both GATA3 and T-bet along with signal-dependent TFs. 62 Similar bivalent histone modifications were also observed at Tbx21, Gata3, and Rorc in T FH cells and at Bcl6 in non-T FH cells, supporting the concept of plasticity between T FH and other T H cell populations. 75 This epigenetic plasticity and observed diverse expression of previously regarded lineage-specific TFs challenges the concept of their role as pure master regulators. 76 Third, polarized T cells might not be stable lineages but represent a continuum of epigenotypes that are more or less susceptible to convert to other lineages through extrinsic signals. Indeed, stimulation of CD4 1 T cells in vitro with different combinations of polarizing cytokines resulted in a continuum of T H cell fates rather than a limited number of clearly defined phenotypes. 77 By additionally taking into account the interdependence of enhancer acetylation and initial TCR signaling strength 43 and the TCR strength-dependent differential TF binding to enhancers and resulting lineage skewing, it seems plausible that epigenomes of T H subsets are staged gradually. It should be noted that cell sorting relies on a relatively small number of surface markers defining presumably homogeneous populations and therefore could have potential contaminations, and this does not allow us to rigorously rule out the possibility that at least some part of the observed T-cell plasticity might in fact arise from these technical limitations. Epigenome-mapping methods at the single-cell level 78, 79 will be able to more accurately address the question of purity, stability, and underlying regulatory networks of the various T H cell phenotypes (Fig 2, C) .
EPIGENETIC MECHANISMS OF TREG CELL DIFFERENTIATION AND TISSUE IDENTITY
The majority of Treg cells are generated in the thymus and characterized by expression of Foxp3. [80] [81] [82] On CD4 lineage decision, some CD4SP cells, after TCR stimulation, upregulate CD25 and TNF family member 18 (GITR) and become Treg precursor cells. 83, 84 During further Treg cell development, several lineage-determining epigenetic events take place (Fig 3) .
In developing Treg cells, a framework of Treg cell-specific epigenetic marks is installed. 84, 85 This epigenetic framework is complemented by expression of Foxp3, which together shape the function and phenotype of mature thymus-derived Treg cells. 86 In the periphery, an additional epigenetic modification event takes place: a tissue-type epigenetic footprint linked to expression of tissue-defining genes. 87 This tissue-type framework can be identified in Treg cell subpopulations from various tissues, such as fat, skin, colon, and lung. Therefore, epigenetic fixation is not only crucial during establishment of thymic Treg cell identity, but also for their functional specialization and adaptation to tissues.
Shaping the Treg cell epigenome in thymic precursor cells
Foxp3-expressing Treg cells develop from CD25
1 Foxp3 2 CD4 SP thymocytes in the thymic medulla. Interestingly, Foxp3 expression alone is not sufficient to induce the complete Treg cell phenotype: it did not induce two thirds of Treg cell signature genes and was not sufficient to establish complete Treg cell functionality. 88, 89 A study helped to identify the missing link between the mature Treg cell transcriptional signature and Foxp3-driven transcriptional changes. 86 Using Foxp3 reporter mice with and without functional Foxp3 protein, it became clear that Foxp3-deficient Treg cells still expressed many Treg cell-associated genes. Molecular analysis through methylated DNA immunoprecipitation sequencing revealed that DNA demethylation of thymic Treg precursor cells regulated the expression of many Treg cell functionassociated molecules, such as cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and CD25, even in the absence of Foxp3. On the other hand, Foxp3-regulated genes, such as Il2, Ifng, or Zap70, were downregulated only on expression of a functional Foxp3 protein.
A recent study using WGBS validated this Treg cell-specific epigenetic signature and identified 339 differentially methylated regions (DMRs) mapping to sites encoding for Ctla4, Ikaros family zing finger 2 (Ikzf2), Ikzf4, Il2ra, and others. 87 This study also confirmed that the thymus-induced epigenetic pattern in Treg cells was stable once Treg cells left circulation and immigrated into peripheral tissues. 87 An additional study characterized the enhancer (H3K27ac) landscape in Treg cells and conventional T (Tconv) cells from secondary lymphoid organs. 84 The authors identified 318 common superenhancer structures, with 66 of those being specific for Treg cells. The enhancer site mapping correlated well with data derived from ATAC sequencing and WGBS, as well as gene expression analysis, identifying superenhancers to be responsible for mediating implementation of the Treg cellspecific epigenetic signature. 84 Many of those superenhancer structures mapped to Treg cell signature genes, such as Foxp3, Ctla4, Il2ra, or Ikzf2. A kinetic analysis of superenhancer activation revealed that about half of the Treg cellspecific superenhancers were active already in Treg precursors cells, preceding expression of the regulated genes. In a search for potential upstream regulators of superenhancer establishment, SATB Homeobox 1 (Satb1) was identified. Satb1 deficiency in Treg precursor cells led to a loss of Treg cell differentiation potential, whereas Satb1 deletion in mature Treg cells had no effect on Treg cell functionality. Taken together, these studies revealed that Treg cells require both an epigenetic framework and the activity of the lineage specification factor Foxp3 to achieve full functionality. 84 
Epigenetic stabilization of Foxp3 gene expression in the thymus
In cooperation with the epigenetic framework established in the thymus, expression of Foxp3 completes the Treg cell-specific transcriptional signature required for full Treg cell functionality. On the other hand, loss of Foxp3 expression causes severe autoimmune disease. [80] [81] [82] Therefore various studies analyzed the Foxp3 gene and its regulation on both epigenetic and transcriptional levels (as reviewed by Delacher et al 90 ).
Interestingly, a detailed sequence comparison of the Foxp3 gene itself revealed many evolutionarily conserved regions, 4 of which were in the noncoding section of the Foxp3 gene (so-called conserved noncoding sequence [CNS] regions), as well as the Foxp3 promoter itself. The first noncoding region, termed CNS0, was identified recently and might act as a pioneering element which subsequently unlocks activity of the remaining CNS regions and the promoter. 84 The Foxp3 core promoter was shown to become demethylated on TCR signaling activity and allows binding of Foxp3-inducing TFs. 91 The promoter is methylated in DN thymocytes and Treg precursor cells, 87 and permissive histone modifications have been identified exclusively in Treg but not Tconv cells. [92] [93] [94] In contrast to the promoter, the CNS1 element was shown to be dispensable for thymic generation of Treg cells but important for induction of peripherally induced Treg cells. 95 CNS1 is demethylated in Treg cells and methylated in Tconv cells. 96 It was classified as TGF-b-sensitive enhancer element, in which permissive histone modifications could be induced by factors such as NFAT and Smad3. 97, 98 Historically, the first CNS region to be identified was the CNS2 region, also called the Treg cell-specific demethylated region. It was located based on its dense CpG motifs and specific binding sites. 99, 100 Furthermore, detailed studies revealed that its epigenetic fixation was an important indicator for the stability of Foxp3 expression mediated by ten-eleven translocation enzymes. 96 CNS2 demethylation protects Treg cells under destabilizing cytokine conditions or under strong proliferative pressure. 101, 102 Finally, the CNS3 region was shown to be critical for initiation of Foxp3 expression: it is enriched in permissive histone modifications and already opened in Treg precursor cells, probably in close interaction with the other pioneering region CNS0. 84 In summary, studies over the last years helped to identify critical epigenetically controlled regulatory elements in the Foxp3 gene, some of which are important for induction of Foxp3 expression in the thymus (CNS0 and CNS3) or periphery (CNS1), as well as its durable expression under cytokine or proliferation pressure (CNS2).
Implementation of an epigenome-based tissue Treg cell signature
Until now, 4 epigenetic events important for the development and function of Treg cells have been listed: T-cell lineage commitment during the DN2-DN3 transition, decision between CD4 or CD8 T-cell fate, implementation of the thymic Treg epigenetic framework, and induction and stabilization of Foxp3 expression. A fifth epigenetic event has recently been described: implementation of a tissue Treg cell-specific epigenetic landscape (Fig 3) . 87 In the past decades, several studies identified a new capacity of Treg cells in addition to their classical role as suppressors of (auto)immune inflammation: they were shown to migrate into tissues, where they can, based on context, provide help in repair of damaged tissue, 103, 104 support tissue function, or prevent tissue damage. [105] [106] [107] [108] [109] [110] By comparing the genome-wide DNA methylation pattern of fat-and skin tissue-derived Treg cells, the authors identified both tissuespecific differences and a global tissular epigenetic framework (Fig 4) . 87 A T H 2-biased Treg cell subset within this framework was termed tissueTregST2 cells because they express the cytokine IL-33 receptor ST2 and can be identified at high frequencies in peripheral tissues. By providing IL-33, the ST2-expressing Treg cell population could be vigorously expanded, whereas deletion of the T cells retain an epigenetic imprint at effector gene loci that allows them to reactivate the effector program on recall. B, Mouse models suggest that TILs can be reinvigorated by checkpoint blockade in early phases of dysfunction and accompanied epigenome remodeling, whereas prolonged exposure to the tumor environment causes severe dysfunction and accompanied epigenome remodeling that fixes TILs in their hyporesponsive state. Hence an epigenetic barrier to T-cell reactivation exists. C, Potential effect on epigenetic heterogeneity and microenvironment-dependent epigenome changes on T-cell function and response to immunotherapy in patients with cancer. Signals that potentially modulate TIL epigenomes are, among others, coinhibitory/costimulatory signals, the strength of antigen affinity, cytokines, metabolites (eg, S-2-hydroxyglutarate depicted here), tissue-specific signals from the cell environment (retinoic acid depicted here as an adipose tissue-derived signal and known inducer of transcription factors in monocytes), and biochemical factors, such as pH or oxygen.
identity of thymus-derived Treg cells on their adjustment to peripheral tissues. It will also be important to understand the epigenetic modifiers within the lymphatic and peripheral tissues. Because it is still difficult to mimic all epigenetic changes in vitro, novel in vivo tools have to be developed. To this end, CRISPR/Cas9-mediated sequence-specific targeting might be a way to dissect the importance of individual loci. In addition to thymus-derived Treg cells, a Treg cell phenotype can be induced in vitro and in vivo in the periphery in previously naive CD4
1
Foxp3
2 T cells by using adequate signals, in which the latter could contribute to the tissue Treg cell pool. Interestingly, in vitro-generated Treg cells show an unstable phenotype using TGF-b, which probably results from incomplete acquisition of a Treg cell epigenome signature. 99 In in vivo peripherally induced Treg cells, the Treg cell-specific demethylated region in the Foxp3 gene, Il2ra, and Ctla4 loci are demethylated similar to what is seen in thymus-derived Treg cells, and adequate markers are needed to distinguish those populations. 87 To this end, HELIOS and RORgt are potential candidates to distinguish between thymus and peripherally induced Treg cells. 111, 112 Indeed, a recent publication showed that Ikzf2 is demethylated in thymus-derived Treg cells, whereas it is fully methylated in RORgt 1 Helios 2 peripherally induced Treg cells. 87 Ideally, single-cell whole-epigenome methods could significantly contribute to a data-driven decomposition of Treg cell subpopulations in tissues, given the known role of the epigenome in determining Treg cell function and stability. This would be particularly relevant to investigate the source of Treg cells in disease settings, such as inflammation, allergy, and cancer.
EPIGENETIC MECHANISMS REGULATING CD8
1
T-CELL RESPONSES AND DIFFERENTIATION
Mature CD8
1 T cells are able to recognize foreign antigen, a process that drives an immune response aimed at eliminating the antigen source and potentially providing a lifelong protection from it. This immune response comprises specific recognition of antigen through TCR peptide/MHC interactions, expansion and differentiation of TCR-specific effector cells that eliminate antigen, and formation of a persisting memory CD8
1 T-cell population that provides protection against the same pathogen in the future. The accompanied gene expression programs that provide CD8
1 T cells with all necessary transcripts and proteins to fulfill their function need to be tightly controlled to ensure a precise immune reaction, which has generated much interest in the epigenetic mechanisms that govern CD8 1 T-cell responses.
Antigen-dependent activation of naive CD8 1 T cells initiates an autonomous program of differentiation and proliferation that equips the lymphocytes with effector function. This includes production of cytokines, such as IFN-g and TNF-a, and expression of cytolytic effector molecules, including perforin and granzymes. After antigen clearance, the large number of expanded CTLs contracts to a small pool of memory T cells that persist once the antigen is eliminated. In contrast to naive CD8 1 T cells, antigen-specific memory CTLs are able to respond quickly on antigen re-encounter without the need for further differentiation. As a first step after T-cell activation, effector genes undergo widespread epigenetic remodeling. A comparison of DNA methylomes of antigen-specific naive and effector T cells during acute lymphocytic choriomeningitis virus infection identified many DMRs between the 2 differentiation states, where DMRs were enriched for TF-binding sites important for T-cell development and function. 113 Interestingly, both loss and gain of DNA methylation were observed during the process of CD8
1 effector T-cell differentiation. Regions that lost DNA methylation facilitated expression of the effector phenotype, whereas regions that gained DNA methylation were overlapping with enhancers active in the thymus, indicating a silencing of specific developmentassociated regulatory elements in the time course of differentiation by activity of the de novo methyltransferase Dnmt3a. The methyltransferase appeared to be dispensable for proper effector function, 114 although more memory precursor and fewer terminal effector cells were observed in Dnmt3a knockout mice, indicating that loss of DNA methylation to activate effector genes is more important for effector function than restricting the noneffector epigenetic program by using de novo methylation. Naive T cells show both permissive (H3K4me3) and repressive (H3K27me3) histone modifications at genes related to proliferation and differentiation, and a loss of repressive H3K27me3 led to quick transcription of related genes. 115 In contrast, many effector loci miss permissive H3K4me3, which needed to be established during effector differentiation to permit transcription. Interestingly, H3K4me2 marks a subset of rapidly transcribed effector genes in naive cells, 115 suggesting that the chromatin at the associated loci is already primed for rapid activation.
CD8
1 T-cell memory differentiation program T-cell memory enables lifelong protection against encountered pathogens. Therefore cellular processes must be in place that ensure memory CD8
1 T cells retain their identity and can quickly turn toward the effector phenotype again. Analysis of the chromatin accessibility landscape demonstrated that memory CD8 1 T cells display a preprogrammed chromatin profile and maintain a molecular history of cis-element usage, thereby reducing the steps necessary to reactivate the molecular effector program. 116 The majority of chromatin-accessibility changes occur during transition of naive to effector T cells, with lower numbers of chromatin regions specifically gaining or losing accessibility during the subsequent differentiation from the effector to the memory T-cell stage. 117 Notably, chromatin accessibility alone is an insufficient proxy for transcription because accessibility in memory cells permitted basal transcription of certain effector genes, such as Ifng, whereas other accessible genes were transcriptionally silent but poised for rapid re-expression on TCR activation, such as granzyme A (Gzma). Nevertheless, chromatin accessibility landscapes in CD8
1 T cells allow inference of distinct candidate TFs that establish and maintain the corresponding chromatin states, which ultimately regulate the formation of effector and memory T-cell subpopulations. 116, 117 Several studies further elucidated the role of histone modifications in CD8
1 T-cell differentiation and memory formation. [118] [119] [120] [121] [122] Although the dynamic regulation of permissive and restrictive histone modifications at promoters provided explanations for gene expression dynamics of important regulators of CD8 1 differentiation, 115, 120, 122 inclusion of distal generegulatory elements revealed a highly dynamic enhancer repertoire that shapes CD8
1 T-cell differentiation and memory formation. 118, 119 Many enhancers were discovered that established, decommissioned, reactivated, and changed the interaction with their target gene promoters during CD8
1 T-cell responses, highlighting that not only the mere mapping of enhancers but also identifying the dynamic interactions with target genes are crucial to understand gene regulation during an immune response.
Although the concept of a poised epigenome landscape in memory T cells to induce an effector program rapidly on recall is established, it is under debate whether CD8
1 memory T cells are derived from a dedifferentiating effector pool after antigen clearance (circular model) or whether they are formed on the way towards terminal effector differentiation (linear model). Although transcriptome studies argue for a linear model of memory CD8
1 T-cell formation, 123 DNA methylation analysis argue more in favor of the circular model: epigenetic repression of naive-associated genes in effector CD8
1 T cells was shown to be reversed in cells that develop into long-lived memory CD8 1 T cells, whereas key effector genes remain demethylated. 124 Notably, epigenetic imprinting of T-cell functionality can last a very long time, which is demonstrated by a vaccination study showing that open chromatin profiles at effector genes were maintained in memory CD8
1 T cells isolated even a decade after vaccination (Fig 5, A) .
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CD8
1 T-cell hyporesponsiveness
In patients with cancer or chronic infections in whom antigen persists, continuous activation can drive T cells into a state of hyporesponsiveness that is also termed T-cell exhaustion or T-cell dysfunction. This T-cell state is characterized by progressive loss of cytokine production, as well as effector function, and by upregulation of several coinhibitory receptors, such as programmed cell death protein 1 (PD-1), TIM3 (HAVCR2), cytotoxic T lymphocyte-associated protein 4 (CTLA-4), or lymphocyte activation gene 3 (LAG3), that further attenuate Tcell responses. 126 Many transcriptome studies tried to dissect the molecular programs that mediate T-cell hyporesponsiveness, but thus far, no exhaustion-specific TFs were identified. 127 Most identified candidate TFs also play a major role in T-cell development and function, which led to the conclusion that the epigenetic landscape might interpret the activity of those TFs in a different manner between normal effector T cells and their dysfunctional counterparts.
To this end, several groups described T-cell hyporesponsiveness as an epigenetic state distinct from normal effector or memory T cells. [128] [129] [130] [131] [132] By probing the chromatin accessibility landscape of T cells from mouse models of cancer or chronic infection, exhaustion-specific differentially accessible chromatin regions with overrepresented TF-binding motifs of NFATc1 and nuclear receptor subfamily member 1 (Nur77), and others were identified as potential drivers of the hyporesponsive chromatin state. Importantly, treatment with immunotherapeutic agents, such as anti-PD-1 antibodies, only caused transient T-cell reinvigoration accompanied by minor chromatin remodeling, suggesting that T-cell dysfunction is fixed at the epigenome level, hence providing an inherent barrier to T-cell reinvigoration (Fig  5, B) . 129, 132 In line with this, earlier studies already described the persisting demethylation of the Pdcd1 promoter (the gene encoding PD-1) in hyporesponsive T cells, which allowed rapid re-expression of this coinhibitory signal on antigen re-encounter, already suggesting epigenetic mechanisms contributing to T-cell dysfunction. 133 These findings were recently corroborated on the genome-wide level, where specific DNA methylation programs that promote T-cell hyporesponsiveness were described. 130 In this study, similar to DNA accessibility, exhaustion-associated DNA methylation programs were largely preserved during PD-1 blockade, supporting the concept of an epigenetic barrier to Tcell immunotherapy. However, genome-wide epigenome studies were performed on bulk populations, and hence it is unclear whether there is a small fraction of cells that significantly responds to therapy but stays unnoticed because of the majority of unresponsive cells. In addition, hyporesponsive T cells are very heterogeneous at the cellular and functional level, 134 which could not be resolved by epigenome studies on bulk populations. Hence, it is still unclear whether hyporesponsive T cells comprise epigenetic heterogeneity, which might have a significant effect on their functionality, underlying gene-regulatory programs, and response to immunotherapy. An answer to those questions might be provided by recently available single-cell epigenome methods, 78, 79, 135 which will further elucidate our molecular understanding on the role of epigenetics in T-cell hyporesponsiveness in the future.
Tissue environment's effect on epigenetics of CD8 
T-cell hyporesponsiveness
Epigenome profiling of hyporesponsive T cells using mouse models concludes that TCR signaling alone induces the epigenetic program of T-cell hyporesponsiveness, irrespective of signals from the tissue microenvironment. 117, 132 Mouse models use high-affinity antigens to activate T cells, but lower-affinity antigens can have a different effect on the epigenomic landscape, potentially allowing CD8
1 T cells to integrate further signals on the epigenome level. In fact, varying TCR signaling strength was shown to directly influence the extent of DNA demethylation at the Pdcd1 promoter. 133 Furthermore, as exemplified in CD4 1 T cells, stimulation with peptides of different TCR affinities translates into differential histone acetylation patterns at T-cell enhancers and dictates genome-wide binding of the TCRinducible TFs BATF and IRF4. 43, 44 In the cancer setting the quality and quantity of antigen can differ widely between distinct tumor microenvironments. Thus it is possible that different TCR activation-driven epigenome states exist among tumorinfiltrating lymphocytes (TILs) that render them receptive to integrating further signals on the epigenome level to ultimately shape the T-cell response and predisposition to therapeutic intervention.
With the known role of costimulatory/coinhibitory signals, cytokines, metabolites, hypoxia, and other factors in T-cell function, it should not be excluded that the tissue/tumor microenvironment can significantly alter T-cell epigenomes. As an example, the metabolite S-2-hydroxyglutarate modulated histone and DNA methylation levels, which ultimately changed surface markers of T-cell differentiation. 136 Lower glucose concentrations in the tumor microenvironment cause increased expression of the microRNAs miR-101 and miR-26a, which leads to decreased expression of the histone methyltransferase Ezh2 and impaired CTL function. 137 In vitro costimulation of CD8
1
T cells with an antibody against TNF family member 9 (4-1BB) induced DNA methylation changes, indicating a direct effect of J ALLERGY CLIN IMMUNOL VOLUME 142, NUMBER 3 immunomodulatory signals present in the tissue environment on the epigenome of T cells (Fig 5, C) .
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A potential influence of the tissue type in which T-cell activation takes place might also explain why there is only minor overlap in the open chromatin regions that was suggested to drive T-cell exhaustion in 2 different murine cancer models, 117 although this could also result from the use of different model antigens and transgenic TCRs. However, with the known effect of tissue adaption in shaping the epigenomes in Treg cells and macrophages, 87, 139 it is possible that distinct signals from the tumor tissue type have an effect on the epigenome of CD8
1 TILs. As a specific example, retinoic acid derived from adipose tissue induces TFs in tissue-specific macrophages to modulate the enhancer landscape in these cells, and it seems likely that also TIL-regulatory programs are shaped by such tissue-dependent signals from tumoral or stromal cells. In light of these observations, it will be interesting to dissect to what extent signals from distinct tissues and other immune cells modulate the epigenomes of lymphocytes and how this translates into modulation of T-cell responses.
CONCLUSIONS AND FUTURE DIRECTIONS
More than 75 years after the initial proposal of the term epigenotype to describe changes in phenotype without changes in genotype, 140 technological improvements and breakthrough discoveries have advanced epigenetics to a vast and growing field of research. During the last decade, reduced sequencing costs and improvements of epigenome-mapping methods have created a wealth of information that allowed the description of epigenomes of immune cells, which enabled us to correlate epigenetic patterns to distinct cellular states and functions and to uncover underlying molecular mechanisms of epigenetic inheritance. Accumulating evidence suggests that interaction of T cells with their tissue environment strongly influences their gene-regulatory landscape in both steady-state and disease conditions. Hence, despite the data already available, these observations imply the need for more context-dependent epigenome profiling of T cells, such as analysis of lymphocytes from patients with different diseases, treatment regimens, anatomic locations, and control cell populations before disease onset to disseminate disease mechanisms. In addition, there is the need to better define the specific effect of nutrients, toxins, metabolites, and further signals from the (tissue) environment that could shape the epigenome and, by doing so, the T-cell response.
A further relevant aspect gaining increased attention is how age shapes T-cell epigenomes because several studies have demonstrated age-dependent changes in chromatin accessibility, DNA methylation, and histone modifications. [141] [142] [143] For instance, DNA methylation patterns in newborns were distinct from middle-aged and adult subjects at immunologically relevant gene loci. 144 Even around birth, a preferential epigenetic priming of T H 2-specific regulatory regions was observed in mouse T cells, a program that is rapidly terminated postnatally, 145 suggesting agedependent skewing of T-cell epigenomes and hence T-cell responses. Because the speed from sample acquisition to data generation is increasing, epigenetic profiles of immune cells can be generated on a personalized basis with the potential yield of clinically relevant information, such as disease classifications, response to treatments, or activity of regulatory elements at disease variants, [146] [147] [148] in a timeframe compatible with clinical decision making.
Most epigenome data on T cells were obtained from bulk cell populations. However, single-cell technologies, such as mass cytometry and single-cell RNA sequencing have revealed unprecedented heterogeneity among T-cell populations. With new single-cell epigenome-mapping technologies on the verge, 78, 79, 135 it will likely soon be possible to deconvolute underlying epigenetic programs to better understand the complex phenotypic heterogeneity of immune cells, which will further increase the relevance of epigenome profiling in clinically relevant questions. With increasing knowledge of T-cell epigenome states and their relevance in T-cell responses, it will be more and more feasible to favorably modify T cells by using epigenetic drugs. The discovery of frequent mutations of epigenetic modifiers in patients with cancer has spawned the development of an evergrowing toolbox of compounds that alter the activity of epigenetic readers, writers, and erasers, which to some extent have already been used to shift T-cell fates and functions. 130, 149 Thus, it is highly likely that future novel treatment approaches targeting the Tcell epigenome will be developed and combined with powerful checkpoint inhibitors to lastingly reactivate and unleash the full potential of tumor-and pathogen-specific T cells.
